FGFR2 and breast carcinoma: For example, three SNPs, rs2981578, rs45631563 and rs35054928, of fibroblast growth factor receptor 2 (FGFR2) are mapped to transcriptional silencer elements and enhance silencer activity, resulting in lower FGFR2 expression and increased risk of breast cancer.31